|
PsyBio Therapeutics Hosting Webinar on The Future of Psychedelic MedicineJoin CEO Evan Levine for an inside look at PsyBio’s innovations in the field of psychedelic medicine. The webinar is open to the public and investors. Register Here |
|
Neovasc Announces First Patient Enrollment in COSIMA TrialNeovasc, Inc. today announced that the first patient has been enrolled in the COronary SInus Reducer for the Treatment of Refractory Microvascular Angina (COSIMA) trial. The enrollment occurred at University Hospital, Mainz, Germany. |
|
Comtech Telecommunication Corp. Awarded $3.0 Million Order for Maintenance of Downrange Tracking StationsComtech Telecommunication announced today, that during its third quarter of fiscal 2021, its Space & Component Technology Group, which is part of Comtech’s Government Solutions segment, was awarded a $3.0 million order from an overseas agency for ground station maintenance and support. Research, News & Market Data on Comtech |
|
Coeur Announces Investment in Victoria Gold Corp.Coeur Mining, Inc. announced today that it has entered into an agreement to acquire 11,067,714 (approximately 17.8%) of the outstanding undiluted common shares of Victoria Gold Corp.(TSX: VGCX) from Orion Co-VI Ltd. |
|
Great Lakes Dredge & Dock Corporation Announces Private Offering of Senior NotesGreat Lakes Dredge & Dock announced it plans to offer $325 million aggregate principal amount of fixed-rate, unsecured senior notes Research, News & Market Data on Great Lakes Dredge & Dock |
|
Cocrystal Pharma Announces Closing of $40 Million Bought Deal
07-May Cocrystal Pharma announces Closing of $40 Million Bought Deal Research, News & Market Data on Cocrystal |
|
Stem Holdings to Present at Canaccord Genuity’s Annual Global Cannabis Virtual Conference on May 11thDriven By Stem announced that Adam Berk, Chief Executive Officer, is scheduled to present virtually at the 2021 Canaccord Genuity Virtual Cannabis Conference, on Tuesday, May 11th at 10:00 a.m. ET Research, News & Market Data on Driven By Stem |
Stay up to date. Follow us: